Clinical Trials Browser

NCT07199413 2025-09-30

Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy: A Phase I Pilot Safety and Feasibility Study for Solid Tumor Patients With CNS Metastases

Phase 1 Not yet recruiting

20 enrolled

CNS

Brain Neoplasms, Meningeal Carcinomatosis

NCT00001379 2025-06-19

Treatment and Natural History Study of Lymphomatoid Granulomatosis

Phase 2 Completed

94 enrolled 20 charts

Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

NCT04116502 2024-11-18

MITHRIDATE

Phase 3 Recruiting

586 enrolled

Myeloid

Polycythemia Vera

NCT01438112 2021-04-14

BOND

Phase 2/3 Terminated

22 enrolled

Genitourinary

Adenoviridae Infections, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Virus Diseases

NCT00577993 2020-11-16

Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients

Phase 3 Completed

210 enrolled 14 charts

Lymphoid

Lymphoma, Lymphoma, Follicular

NCT04301908 2020-03-10

A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis

Unknown

10,000 enrolled

Gastrointestinal

Heartburn, Hepatitis B, Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT01658813 2018-03-21

5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer

Phase 2 Completed

18 enrolled 2 charts

GastrointestinalGenitourinaryThoracic

Gastrointestinal Cancer Metastatic

NCT00311558 2018-01-26

Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma

Phase 1 Terminated

18 enrolled

DermatologicSarcoma

Melanoma, Neoplasms, Sarcoma

NCT01276730 2017-12-29

Advanced Cervical Cancer Trial in India

Phase 2 Completed

209 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT00001228 2017-07-02

Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer

Phase 2 Completed

50 enrolled

Adenoma, Islet Cell, Zollinger-Ellison Syndrome

NCT00842114 2016-04-04

LNH-Pro-05

Phase 2 Completed

50 enrolled

Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT00276536 2015-10-14

IFNa

Phase 1 Completed

35 enrolled

BreastDermatologicGenitourinaryLymphoidPlasma cellSarcoma

Breast Neoplasms, Kidney Neoplasms, Lymphoma, Melanoma, Multiple Myeloma, Sarcoma

NCT00352859 2014-12-30

Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib

Phase 4 Terminated

2 enrolled

Genitourinary

Carcinoma, Renal Cell, Neoplasms

NCT00117637 2014-10-31

BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma

Phase 2 Completed

189 enrolled 44 charts

Genitourinary

Carcinoma, Renal Cell, Neoplasms

NCT01782508 2013-02-04

A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma

Phase 2 Unknown

40 enrolled

Dermatologic

Melanoma

NCT00962715 2012-08-03

Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Influenza, Human, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01409187 2012-01-26

IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma

Phase 1/2 Withdrawn

Dermatologic

Melanoma

NCT00250796 2010-01-07

Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma

Phase 2 Completed

12 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

NCT00390897 2008-11-27

Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia

Phase 4 Completed

360 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00309530 2006-04-03

Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C

Phase 3 Completed

598 enrolled

Gastrointestinal

Colonic Neoplasms

NCT00140569 2005-09-01

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

Phase 3 Completed

400 enrolled

Lymphoid

Lymphoma, Follicular